InxMed
Shanghai
About InxMed
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equipped with global-level top-notch know-how and efficient execution capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $128.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2025)
- Website: en.inxmed.com
- Phone: +0086-21-50630108
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/inxmed-99121 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.